Literature DB >> 624050

Schistosomiasis, metriphonate, cholinesterase, and suxamethonium.

M F James, J M Jewsbury.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624050      PMCID: PMC1602981          DOI: 10.1136/bmj.1.6110.442

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  SERUM CHLONESTERASE ACTIVITY DURING PREGNANCY, LABOR AND THE PUERPERIUM.

Authors:  S M SHNIDER
Journal:  Anesthesiology       Date:  1965 May-Jun       Impact factor: 7.892

2.  Pharmacology of organophosphorus cholinesterase inhibitors.

Authors:  B HOLMSTEDT
Journal:  Pharmacol Rev       Date:  1959-09       Impact factor: 25.468

3.  Comparison of the respiratory effects of suxamethonium and suxethonium in man.

Authors:  F F FOLDES; M SWERDLOW; E LIPSCHITZ; G R VAN HEES; S P SHANOR
Journal:  Anesthesiology       Date:  1956 Jul-Aug       Impact factor: 7.892

4.  Treatment of urinary schistosomiasis. Practice and theory.

Authors:  D M Forsyth; C Rashid
Journal:  Lancet       Date:  1967-01-21       Impact factor: 79.321

5.  Treatment of urinary schistosomiasis with trichlorophone.

Authors:  D M Forsyth; C Rashid
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

6.  Effect of metrifonate on blood cholinesterases in children during the treatment of schistosomiasis.

Authors:  R P Davis; D R Bailey
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

7.  Serum cholinesterase, pregnancy and suxamethonium.

Authors:  J A Wildsmith
Journal:  Anaesthesia       Date:  1972-01       Impact factor: 6.955

8.  Field trial of metrifonate in the treatment and prevention of schistosomiasis infection in man.

Authors:  J M Jewsbury; M J Cooke; M C Weber
Journal:  Ann Trop Med Parasitol       Date:  1977-03

9.  Metrifonate in urinary schistosomiasis.

Authors:  A Davis; D R Bailey
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.